The following DT40 cell lines were used: wild-type Clone18,52 (link)BRCA1−/− and BRCA1+/− mutants,19 (link)BRCA2−/− and BRCA2+/− (originally termed BRCA2-/con1),20 (link)PCNAK164R/K164R (referred to in the text as PCNAK164R).33 (link) All gene mutations were authenticated using the whole-genome sequence data. Cells were grown at 37 °C under 5% CO2 in Roswell Park Memorial Institute-1640 medium supplemented with 7% fetal bovine serum and 3% chicken serum. MMS (Sigma-Aldrich, St Louis, MO, USA) or mock treatments were performed on one million cells for 1 h. Single cell clones were isolated and expanded to two million cells prior to genomic DNA preparation using the Gentra Puregene Cell Kit (Qiagen, Hilden, Germany). MMS sensitivity was measured by counting surviving cell colonies after plating treated cells in medium containing 1% methylcellulose.
Free full text: Click here